Stockscreener 앱 받기
41.37
7.96%
3.05
시간 외 거래:
41.85
0.48
+1.16%
전일 마감가:
$38.32
열려 있는:
$37.6
하루 거래량:
1.57M
Relative Volume:
1.39
시가총액:
$2.95B
수익:
-
순이익/손실:
$-299.62M
주가수익비율:
-8.8703
EPS:
-4.6639
순현금흐름:
$-241.73M
1주 성능:
+0.49%
1개월 성능:
-1.85%
6개월 성능:
+61.66%
1년 성능:
+49.35%
1일 변동 폭
$37.51
$41.48
1주일 범위
$37.51
$42.73
52주 변동 폭
$18.53
$56.05
베라 테라 Stock (VERA) Company Profile
명칭
Vera Therapeutics Inc
전화
650-770-0077
주소
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
Compare VERA vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VERA
Vera Therapeutics Inc
|
41.37 | 2.73B | 0 | -299.62M | -241.73M | -4.6639 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
베라 테라 Stock (VERA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-11 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-10-16 | 개시 | BofA Securities | Buy |
| 2025-08-04 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2025-05-05 | 재개 | H.C. Wainwright | Buy |
| 2025-02-04 | 개시 | Wolfe Research | Outperform |
| 2025-01-28 | 개시 | Goldman | Buy |
| 2024-11-21 | 개시 | Wells Fargo | Overweight |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-01-25 | 개시 | Oppenheimer | Outperform |
| 2024-01-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-12-18 | 개시 | Raymond James | Outperform |
| 2023-11-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-08-16 | 개시 | Guggenheim | Buy |
| 2023-01-04 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-01-04 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2022-07-12 | 개시 | JP Morgan | Overweight |
| 2022-05-02 | 개시 | H.C. Wainwright | Buy |
| 2022-04-19 | 개시 | Wedbush | Outperform |
모두보기
베라 테라 주식(VERA)의 최신 뉴스
Volume Summary: What is the next catalyst for Vera Therapeutics Inc2026 Top Decliners & Weekly Setup with High ROI Potential - baoquankhu1.vn
Deep Track Capital, LP Increases Stake in Vera Therapeutics Inc - GuruFocus
Algert Global LLC Acquires 39,235 Shares of Vera Therapeutics, Inc. $VERA - MarketBeat
Vera Therapeutics (VERA) finance chief exercises options for 10,000 shares - Stock Titan
This Biotech Stock Surged 75% Last Quarter and Pulled a New $9 Million Investment - AOL.com
Eversept Partners Increases Stake in Vera Therapeutics - Intellectia AI
Assessing Vera Therapeutics (VERA) Valuation As Deerfield Ups Stake And FDA Priority Review Nears - simplywall.st
HighVista Strategies LLC Increases Position in Vera Therapeutics, Inc. $VERA - MarketBeat
Vera Therapeutics, Inc. $VERA Shares Sold by First Light Asset Management LLC - MarketBeat
Cinctive Capital Management LP Sells 65,510 Shares of Vera Therapeutics, Inc. $VERA - MarketBeat
Braidwell LP Takes Position in Vera Therapeutics, Inc. $VERA - MarketBeat
Wall Street analysts see a 53.05% upside in Vera Therapeutics (VERA): Can the stock really move this high? - MSN
Integral Health Asset Management LLC Has $49.40 Million Stock Holdings in Vera Therapeutics, Inc. $VERA - MarketBeat
Avoro Capital Advisors Reduces Stake in Vera Therapeutics - National Today
Avoro Capital Advisors LLC Sells 90,000 Shares of Vera Therapeutics, Inc. $VERA - MarketBeat
This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision - The Motley Fool
This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision - The Motley Fool
Vera Therapeutics, Inc. $VERA Holdings Raised by Schroder Investment Management Group - MarketBeat
Published on: 2026-03-13 13:04:33 - baoquankhu1.vn
Aug Big Picture: What is the cash position of Vera Therapeutics Inc2026 Price Action Summary & Weekly Stock Breakout Alerts - baoquankhu1.vn
Vera Therapeutics urges expanded innovation in global kidney health on World Kidney Day - Traders Union
Wolfe Research upgrades Vera Therapeutics (VERA) - MSN
Quarterly Trades: Can Vera Therapeutics Inc deliver consistent EPS growth2026 Investor Takeaways & Community Shared Stock Ideas - baoquankhu1.vn
Deep Track files 13G disclosing 5.50% stake in Vera Therapeutics (NASDAQ: VERA) - Stock Titan
Vera Therapeutics (NASDAQ:VERA) Upgraded to Outperform at Wolfe Research - MarketBeat
How (VERA) Movements Inform Risk Allocation Models - Stock Traders Daily
Wolfe Research upgrades Vera Therapeutics stock rating on valuation By Investing.com - Investing.com Canada
Vera Therapeutics (NASDAQ:VERA) Trading Up 10.2%What's Next? - MarketBeat
Vera Therapeutics’ Atacicept Gains FDA Priority, Stock Soars - StocksToTrade
Vera Therapeutics stock rating reaffirmed at Buy by BofA Securities - Investing.com Canada
Vera Therapeutics Adds Christopher Hite to Board - TipRanks
Vera Therapeutics appoints Christopher Hite to Board as Class III Director - TradingView
Director at Vera Therapeutics (VERA) receives grant of 24,937 stock options - Stock Titan
Director Christopher Hite files initial Form 3 at Vera Therapeutics (VERA) - Stock Titan
Christopher Hite joins Vera Therapeutics (NASDAQ: VERA) board of directors - Stock Titan
Vera Therapeutics Appoints New Board Member - Intellectia AI
Rhenman & Partners Asset Management AB Invests $3.78 Million in Vera Therapeutics, Inc. $VERA - MarketBeat
Can Vera Therapeutics Inc. stock deliver surprise earnings beat2026 EndofYear Setup & Weekly Return Optimization Plans - Naître et grandir
GW&K Investment Management LLC Reduces Stake in Vera Therapeutics, Inc. $VERA - MarketBeat
Six new Vera Therapeutics hires receive 4-year stock awards - Stock Titan
Vanguard Group Inc. Has $92.72 Million Position in Vera Therapeutics, Inc. $VERA - MarketBeat
Vera Therapeutics Appoints Christopher Hite to Board of Directors - Sahm
Vera Therapeutics adds Christopher Hite to board of directors By Investing.com - Investing.com Canada
Vera Therapeutics adds Christopher Hite to board of directors - Investing.com
Vera Therapeutics appoints Christopher Hite to board of directors - marketscreener.com
Vera Therapeutics Appoints Christopher Hite To Board Of Directors - TradingView
Royalty Pharma vice chair joins Vera board before potential IgA drug launch - Stock Titan
Q1 EPS Estimates for Vera Therapeutics Cut by HC Wainwright - MarketBeat
Sofinnova stake in Vera Therapeutics (VERA) drops below 5% threshold - Stock Titan
Vera Therapeutics Files BLA for Atacicept in IgAN, Target Action Date July 7, 2026 - Intellectia AI
Vera Therapeutics, Inc. (VERA) Stock Analysis: 94.88% Potential Upside Signals Compelling Opportunity - DirectorsTalk Interviews
베라 테라 (VERA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
베라 테라 주식 (VERA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Brenner Robert | Chief Medical Officer |
Feb 23 '26 |
Sale |
41.98 |
2,151 |
90,307 |
50,947 |
| Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR |
Feb 23 '26 |
Sale |
41.98 |
3,117 |
130,864 |
64,722 |
| Grant Sean | CHIEF FINANCIAL OFFICER |
Feb 23 '26 |
Sale |
41.98 |
4,949 |
207,778 |
114,181 |
| Fordyce Marshall | PRESIDENT AND CEO |
Feb 23 '26 |
Sale |
41.98 |
16,925 |
710,578 |
257,163 |
| JOHNSON DAVID LEE | Chief Operating Officer |
Feb 23 '26 |
Sale |
41.98 |
2,579 |
108,276 |
45,727 |
| Turner William D. | Chief Regulatory Officer |
Feb 23 '26 |
Sale |
41.98 |
2,187 |
91,819 |
45,313 |
| Skelton Laurence Matthew | Chief Commercial Officer |
Feb 23 '26 |
Sale |
41.98 |
1,582 |
66,419 |
64,218 |
1.20%
0.06%
자본화:
|
볼륨(24시간):